Sunday, 24 June 2018

Cardiovascular Information System Market Analysis Report with Demand and Challenges of the Key Industry Players & Market Forecast, 2023

The global cardiovascular information system market is witnessing significant growth due to increasing prevalence of cardiovascular diseases, growing government initiates towards electronic health record system implementation and growing rate of medication errors. The remote access to data and images, and reduced IT burden in the diagnostic center and hospitals are supporting the demand of CVIS.

The increasing demand for cloud based solutions is expected to create opportunities for the players in the market. The unexplored market in developing economies is also creating abundant opportunities for the cardiovascular information system market to grow at a significant rate in the coming years.


Cardiovascular disease is the disease of heart and blood vessels, which includes conditions such as hypertension, coronary heart disease, heart failure, cerebrovascular disease and rheumatic heart disease. According to the WHO, globally about 17.5 million people died due to cardiovascular diseases in 2012, while the number is expected to reach 23.3 million by 2030.


Cardiovascular information system is imaging and analytical data handling software for cardiology department. It is designed to feature single database design for hemodynamics monitoring, echocardiography, vascular ultrasound, nuclear cardiology, ECG management, electrophysiology reporting and cardiac and peripheral catheterization. The adoption of CVIS solution is increasing for reducing the mortality rate due to cardiovascular disease and to streamline cardiac care workflow in healthcare organization. The solution helps to improve patient safety and quality of care, improve efficiency and reduce errors by eliminating duplicate entry, streamline cardiovascular information system workflow, increase productivity and strengthen referral relationships by expediting report creation. CVIS enables physicians to take accurate therapeutic decision in less time.

Geographically, North America has been the largest market for cardiovascular information system, owing to increasing incidence of cardiovascular disease, well established healthcare infrastructure, and strict privacy and security regulation in the region.

Globally, the cardiovascular information system market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to large pool of patient, improving healthcare infrastructure, increasing incidence of cardiovascular disease, and growing medicmedical tourism in the region.


The key players operating in the global cardiovascular information system market are Philips Healthcare, McKesson Corporation, Philips Healthcare, General Electric Company, Siemens AG, AGFA Healthcare and Cerner Corporation.

Saturday, 23 June 2018

Hospital Capacity Management Solutions Market Outlook Report | Growth and Demand Forecast to 2023

Hospital capacity Management Solution Market

The growing demand of better healthcare facilities, and technological advancement in hospital capacity management solutions are the major growth drivers for the global hospital capacity management solutions market. Additionally, the increasing investment by healthcare IT companies, growing demand for integrated healthcare solutions, and increasing number of hospitals are also driving the growth of the global hospital capacity management solutions market.

The capacity management solutions help in increasing the efficiency of workflow and reduce expenses in hospitals. Moreover, these solutions provide support in bed management, asset management, and quality patient care. The bed management solutions track hospital bed utilization rates and manage all process from bed admission to their maintenance. The asset management solutions manage the usage patterns of high-end equipment and their proper utilization.


The stringent regulation for the installation and implementation of capacity management solutions in hospitals is restraining the growth of the market. Moreover, the high installation and maintenance costs of these systems, and lack of skilled healthcare professionals is also hindering the growth of the global market, especially in the developing countries, such as India and China.


Hospital Capacity Management Solutions Market Segmentation


By Solutions

  • Quality Patient Care Solutions
  • Bed Management Solutions
  • Asset Management Solutions
    • Radiology Utilization Management Solutions
    • Laboratory Equipment Management Solutions
  • Workflow Management Solutions
  • Patient Flow Management Solutions
By Geography
  • North America
    • S.
    • Canada
  • Europe
    • Germany
    • France
    • K.
    • Spain
    • Italy
  • Asia
    • Japan
    • China
    • India
  • Latin America
    • Brazil
  • Rest of the World
North America and Europe are the major markets for the hospital capacity management solutions, due to increasing prevalence of chronic diseases, and improved healthcare infrastructure in these regions. Additionally, the technological advancement in hospital capacity management solutions and increased awareness about potential applications of these solutions is also playing a pivotal role in growth of the market within these regions.

The Asian market is growing with a significant rate, owing to increasing number of hospitals, and increasing healthcare spending in the region. In addition, the initiatives taken by various government associations for the implementation of healthcare IT in hospitals are also supporting the growth of the Asian hospital capacity management solutions market. The countries, such as India, Japan and China, are the major markets in the region.


Some of the major players operating in the global hospital capacity management solutions market include Infosys Limited, TeleTracking Technologies Inc., NextGen Healthcare Information Systems LLC, GE Healthcare, McKesson Corporation, Cerner Corporation, STERIS Corporation, Alcidion Corporation, and Central Logic.

Wednesday, 20 June 2018

Blood Collection Market Outlook, Opportunities, Challenges, Trends, Size and Growth, Competitive Analysis, Major Competitors and Porter Analysis



The global blood collection market is witnessing considerable growth due to increasing geriatric population, increasing number of accidental cases and growing surgical procedures. Moreover, growing prevalence of chronic diseases including cancer, cardiovascular disease, infectious diseases, autoimmune diseases, diabetes mellitus, and infectious diseases is supporting the growth of the market.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/blood-collection-market/report-sample

Based on product type, the blood collection needle and syringe segment lead the market. The increasing demand of needle and syringe for blood collection across the globe, owing to their easy availability and ease of use, is driving the growth of this segment. In addition, rising initiatives undertaken by government associations to boost awareness about blood donations and advanced features of blood collection products are also supporting to the growth of this market.

Access Detailed Report Summary @ https://www.psmarketresearch.com/market-analysis/blood-collection-market

Geographically, North America has been the largest market for blood collection, owing to increased awareness, established healthcare industry, and easy increasing prevalence of infectious and non-infectious diseases in the region.Europe has been the second largest market for blood collection.

Globally, the blood collection market is expected to witness the fastest growth in Asia-Pacific during the forecast period. The highest growth in the region is attributed to the increasing prevalence of chronic diseases, increasing per capita income leading to increasing standard of living, increasing healthcare spending, growing demand for better quality medical care, and awareness about blood collection tests in the region.

The key players operating in the global blood collection market are Abbott Laboratories Inc., Becton, Dickinson and Company, Terumo Corporation, Sarstedt AG & Co., Nipro Medical Corporation, Qiagen, Haemonetics Corporation, Greiner Holding AG and F.L. Medical SRL.

Tuesday, 19 June 2018

Topical Drug Delivery Market Business Overview, Challenges, Opportunities, Trends and Market Analysis by 2023

Topical Drug Delivery Market 

Drugs that are applied to a local area on the body are known as topical drugs. Many creams and balms that are used for skin treatment are frequently called topical drug. 

Eye drops for ophthalmic use and various drugs utilized for inward breath in respiratory conditions such as asthma are also frequently known as topical medications. Topical medications have a local effect that means the effect of the drug will be only in the area where the drug has been applied; however, some topical medications can also have a systemic effect.


Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/topical-drug-delivery-market/report-sample

On the basis of route of administration, global topical drug delivery market is segmented into skin, ophthalmic, nasal, rectal and vaginal drug delivery routes. Skin drug delivery holds the largest share of the global market, which is attributable to the high incidence of skin diseases, rise in the demand for self-administered drugs, and the increasing number of product approvals for skin-related drug delivery systems.

Access Detailed Report Summary@ https://www.psmarketresearch.com/market-analysis/topical-drug-delivery-market

There are various factors that drive the growth of the topical drug delivery market including the increasing prevalence of dermal diseases, development of high technology in topical drug delivery systems, high number of cases of burn injuries, and increasing prevalence of diabetes, globally. 

According to the information published by Pharmaceuticals Research and Manufacturers of America (PhRMA), the member organizations of PhRMA spent approximately $58.8 billion on R&D, accounting for the larger part of all the biopharmaceutical R&D spending in the U.S., in 2015. 

Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=topical-drug-delivery-market

Some of the other key players operating in the global topical drug delivery market include Crescita Therapeutics Inc., SOLVAY S.A., Bayer AG, Cipla Limited, Galderma S.A, GlaxoSmithKline PLC, Janssen Global Services, LLC. (Johnson and Johnson), Novartis International AG, Sienna Biopharmaceuticals, Inc., Allergan PLC.

Monday, 18 June 2018

Coagulation Testing Market 2018 Size, Growth and Demand with Global Forecasts to 2023

Coagulation Testing Market
The increasing prevalence of various blood clotting disorders, such as deep vein thrombosis (DVT), hemophilia and thrombophilia, and growing aging population around the world are the predominant growth drivers for the global coagulation testing market. Additionally, the technological advancements in coagulation testing devices and initiatives taken by various government associations to raise awareness about various blood disorders and its management are also driving the growth of the market.
 
 
Coagulation testing procedures are used to measure the ability of blood to develop clot in blood vessel. Testing helps doctors to assess the risk of excessive bleeding and developing clots, also known as thrombosis, in blood vessels. Various types of coagulation tests exists, and the major types include complete blood count (CBC), fibrinogen level, Factor V assay, prothrombin time (PT or PT-INR), platelet count, thrombin time, and bleeding time.
 
North America and Europe are the major markets of coagulation testing, due to rapid launch of anticoagulants, increasing incidences of blood clotting disorders, and growing demand for coagulation testing devices. The U.S., followed by Canada is the largest market for coagulation testing in North America. Whereas, Germany, the U.K., France, and Italy are some of the major countries holding significant shares in the European market.
The Asian market is growing with a significant rate, owing to increasing prevalence of blood disorders, growing aging population, and increasing healthcare spending in the region. In addition, the initiatives taken by various government associations to raise awareness about various blood disorders and its management are also supporting the growth of the Asian coagulation testing market. The countries, such as India, Japan, and China are the major markets in the region.


Some of the major players operating in the global coagulation testing market include Alere Inc., Thermo Fisher Scientific Inc., Sysmex Corporation, Siemens AG, F. Hoffmann-La Roche AG, Abbott, Axis-Shield Diagnostics Ltd., Danaher Corporation, Becton, Dickinson and Company, Bio/Data Corporation, and Chrono-Log Corporation.

About P&S Market Research

P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
 
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)

Thursday, 14 June 2018

Weight Management Market Outlook, Opportunities, Challenges, Trends, Size, Growth Rate and Forecast, 2023

The global weight management market is growing significantly due to escalating technological advancement, increasing innovation in weight management ingredients, and increasing prevalence of obesity. According to National Health and Nutrition Examination Survey (NHANES) in 2009-10, more than 78 million U.S. adults were obese. Similarly, as per World Health Organization (WHO), approximately 2.8 million people die each year due to obesity.
The weight management market is categorized on the basis of diet and equipment. On the basis of diet, the market can be categorized as meals, supplements, and beverages. Diet leads the market due to increasing prevalence of obese cases, technological advancement and increasing health consciousness of people. The meals can be further segmented as meal replacement, organic food and others; whereas, supplements can be segmented as protein, fiber and others.
Some of the factors driving the growth of the global weight management market are increasing rate of obesity, increasing disposable income, increasing government support, and technological advancements. In addition, increasing prevalence of lifestyle associated diseases, sedentary lifestyle, increasing number of bariatric surgeries, and increasing medical tourism are some of the factors also expected to fuel the growth of the global weight management market in the projected period.
Geographically, North America will be leading the global weight management market in the coming years, due to increasing prevalence of obesity, increase in childhood obesity, strong government support and funding, and change in lifestyle and junk food habits. In addition, increasing membership of health clubs and technological advancement are also driving the growth of the market in North America.
Asia-Pacific is the fastest growing region in the global weight management market. The major reasons for the fastest growth of weight management market in the region are increasing medical tourism, large pool of patients, and increasing healthcare expenditure. Moreover, the weight management market is growing due to increasing awareness of weight management, and refining healthcare infrastructure in the emerging countries, such as India and China, of Asia-Pacific region.
Some of the companies operating in the global weight management market are Amer Sports, Technogym SPA, Weight Watchers International Inc., Ediets.Com Inc., Jenny Craig Inc., Medtronic Inc., Kellogg Company, Brunswick Corporation, Jenny Craig Inc., Atkins Nutritionals Inc., Herbalife Ltd., Apollo Endosurgery Inc., Nutrisystem Inc., Cyber International, Inc., and Johnson & Johnson.

Tuesday, 12 June 2018

Sterilization Equipment and Disinfectants Market Overview, Challenges, Opportunities, Trends and Market Analysis by 2023



The global sterilization equipment and disinfectants market is growing significantly due to technological advancement such as innovation of E-beam and gamma beam in the industry. Sterilization equipment and disinfectants are elemental procedures used to eliminate or control various infectious agents, such as virus and bacteria. The increasing use of these in hospitals, clinics, and laboratories, to reduce the hospital acquired infection, support the growth of the sterilization equipment and disinfectants market.


On the basis of products, the sterilization equipment market can be categorized as heat sterilizers, low temperature sterilizers, radiation sterilization and filtration sterilization. The heat sterilization equipment leads the sterilization equipment and disinfectants market due to its user friendly and secure nature; whereas, the low temperature sterilizers are expected to grow at the fastest rate in the coming years due to its complex and advanced sterilizing efficiency for medical devices, such as endoscopes. Heat sterilization is further categorized as autoclave, hot air oven, and others. Low temperature sterilizers include ethylene oxide sterilization, hydrogen peroxide gas plasma, and vaporized hydrogen peroxide. Whereas, the radiation sterilization includes gamma sterilization, electron beams sterilization, and others.

Some of the factors driving the growth of sterilization equipment and disinfectants market are rise in geriatric population, rise in number of surgeries in hospitals and clinics, and increasing number of hospital acquired infection. In addition, increasing healthcare expenditure and increasing prevalence of diseases, such as cancer and tuberculosis, are also expected to fuel the growth of the global sterilization equipment and disinfectants market.

Geographically, North America will be leading the global sterilization equipment and disinfectants market in the coming years due to rise in aging population, and increasing demand of non-disposable surgical instruments, such as endoscopy devices and forceps. Moreover, Asia-Pacific is the fastest growing region in the global sterilization equipment and disinfectants market. The major reasons for the fastest growth in the region are increasing healthcare expenditure, increasing prevalence of infectious diseases, and large pool of patients in the region. Moreover, the sterilization equipment and disinfectants market is growing due to increasing awareness of healthcare in the emerging countries, such as India and China, of Asia-Pacific region.


Some of the companies operating in the sterilization equipment and disinfectants market are 3M, Cantel Medical Corporation, Belimed AG, TSO3 Inc., Getinge Group, CISA Group, Advanced Sterilization Products Services Inc., Synergy Health Plc, STERIS Corporation, Kimberley-Clark Corporation, Nordion Inc., and Sakura SI Co.Ltd.

Thursday, 7 June 2018

North America Air Quality Monitoring Market by Product, Pollutant, Sampling Method, End User & Geography | Global Research Report, 2012-2022


The North American AQM market valued $1.4 billion in 2015 and is expected to attain a value of $2.5 billion by 2022, growing at a CAGR of 8.5% during the period 2016–2022.

Between the two types of AQM products, indoor monitors accounted for the larger share in the North American AQM market in 2015, due to their high rate of adoption in pharmaceutical and other industries owing to the need for controlled environment. Based on the type of pollutants monitored in 2015, chemical pollutants monitoring generated the largest revenue in the AQM market, followed by physical and biological pollutants monitoring.

Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/north-america-air-quality-monitoring-market/report-sample

The North American AQM market accounted for the largest share in the global AQM market in 2015 mainly due to rising pollution levels in the region, growing number of patients with respiratory disorders, and increasing awareness about environmental and healthcare implications of air pollution. According to the World Health Organization (WHO), approximately 324,000 new cases of lung cancer were reported in North America in 2012 and the number is estimated to reach approximately 541,000 by 2030.

Access Detailed Report Summary@ https://www.psmarketresearch.com/market-analysis/north-america-air-quality-monitoring-market

Technological advancements by scientists and engineers in the field of AQM are changing the way air quality is monitored. Low-cost, portable air sensors are being developed to monitor pollutants in the air, especially in roadways, rail yards, ports, and industrial areas that abide by air quality standards. However, limitations of AQM products, such as limited temporal and spatial coverage by air quality monitors hindering the complete assessment of air pollutants and their health hazards, are impeding their market growth in the region.


Make Enquiry Before Buying the Report@ https://www.psmarketresearch.com/send-enquiry?enquiry-url=north-america-air-quality-monitoring-market

Some of the key players operating in the North American AQM market are the 3M Company, General Electric, Thermo Fisher Scientific Inc., TSI Inc., Emerson Electric Co., Teledyne Technologies Inc., Cerex Monitoring Solutions LLC, PerkinElmer, Inc., and Tisch Environmental Inc.


Tuesday, 5 June 2018

High Throughput Screening Market Considerable Growth due to Increasing Geriatric Population, Healthcare Expenditure and Research & Development Activities


The global high-throughput screening market is witnessing considerable growth due to increasing geriatric population, increasing healthcare expenditure, increasing research and development activities, launch of technologically advanced products that are miniaturized and automated and growing popularity of high-throughput screening for drug discovery.
Moreover, high adoption of high-throughput screening models in pharmaceutical and biotechnology companies across the globe is supporting the growth of the market. Based on technology, 2D cell culture segment is expected to grow at the fastest rate during the forecast period owing to its low cost and ease of use.
The rapid growth in emerging economies and growing research and development activities on stem cells and toxicology is expected to create opportunities for the manufacturers of high-throughput screening products. However, high cost of high-throughput screening, lack of trained professionals and complexity in assay development are the key factors hampering the growth of the global market.
Geographically, North America has been the largest market for high-throughput screening, owing to its increased awareness, increasing government funding, established healthcare industry, and easy accessibility to advanced technologies due to the awareness in the region. The U.S. contributed largest revenue to the North American as well as global high-throughput screening market.
The key players operating in the global market are Agilent Technologies, Inc, Danaher Corporation, Thermo Fisher Scientific Inc., Merck Millipore, Bio-Rad Laboratories, Inc., Hamilton Company and Aurora Biomed, Inc.

Sunday, 3 June 2018

Biomarkers Market Report with Worldwide Market Size, Status, Growth Rate and Future Prospects by 2023


A biological marker, commonly known as a biomarker, measures and evaluates biological and pathogenic processes. It also measures pharmacological responses to a therapeutic intervention. Biomarkers are used in predictions, cause, diagnosis, progression, regression and outcome of various diseases. Biomarkers can be specific cell, molecules, genes, gene products, enzymes, hormones, complex organ functions, and general characteristic changes in biological structure.


Factors such as rising demand of personalized medicine, and companion diagnostics are some of the major growth drivers for the global biomarker market. Recent advancements in the discovery technologies such as genome sequencing are also contributing to the overall growth of the global biomarker market. Increasing personalized solution for cancer treatment, and prevention, rising interdisciplinary systems biology approach and development of OMICS technology is expected to drive the market during the forecast period. 


North America was the largest market of biomarkers in 2014. The market dominance of North America is attributed to the high concentration of pharmaceutical company and their research and development (R&D) center in this region, also the aging population and rising healthcare expenditure in North America is fueling the demand of biomarker in this region. Asia-Pacific market is estimated to be fasted growing market of biomarkers in coming years, attributed to the rising healthcare infrastructure and rising healthcare awareness among the consumers in developing countries. Country wise the U.S. and Canada are some of the major market of biomarkers in North America. Italy, Germany, Spain, the U.K., and France are some of the dominant biomarker market in Europe. China, India, and Japan are major biomarker market in Asia-Pacific. 


Some of the major players operating in the global biomarkers market include, Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., Dickinson and Company, Becton, Celera Corporation., Epigenomics AG., Bruker Corporation, DiagnoCure Inc., GE Healthcare, Siemens AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Clarient Inc., hermo Fisher Scientific, Inc., Epistem Ltd., and Aushon BioSystem Inc.,